Evidence map›Paper›PMID 31444271›Full record

ArticleThe Journal of biological chemistry2019

The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine.

Swetha Parvathaneni, Sudha Sharma

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Human RecQ Helicases in DNA Double-Strand Break Repair.Frontiers in cell and developmental biology · 2021
    Review
  13. Review
  14. RecQ DNA Helicase Rqh1 Promotes Rad3Molecular and cellular biology · 2020
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Swetha ParvathaneniDepartment of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, D. C. 20059.
Sudha SharmaDepartment of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, D. C. 20059 sudha.sharma@howard.edu.ORCID 0000-0003-2765-2482
Howard University · US

Funding

Advancing aging research through development of minority GerontologistsR25AG047843 · NIA · HOWARD UNIVERSITY · PI DUTTAROY, ATANU · 2014 to 2024
$3.3M
Molecular Analysis of RECQ1 Functions in Genome MaintenanceSC1GM093999 · NIGMS · HOWARD UNIVERSITY · PI SHARMA, SUDHA · 2010 to 2019
$3.0M
NIA NIH HHS R25 AG047843NIGMS NIH HHS SC1 GM093999
6 · The paper itself

Abstract

The response of cancer cells to therapeutic drugs that cause DNA damage depends on genes playing a role in DNA repair. RecQ-like helicase 1 (RECQ1), a DNA repair helicase, is critical for genome stability, and loss-of-function mutations in the

Indexed as

Antineoplastic AgentsCell Line, TumorDeoxycytidineDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA RepairEndonucleasesGemcitabineHumansRecQ HelicasesAntineoplastic AgentsDeoxycytidineDNA-Binding ProteinsEndonucleasesGemcitabineMUS81 protein, humanRecQ HelicasesRECQL protein, humananticancer drugbreast cancercheckpoint controlDNA damage responseDNA helicaseDNA repairgemcitabinegenome stabilitymissense mutationRecQreplication stress

Identifiers

PMID31444271
PMCPMC6802502
OpenAlexW2969355628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.